China plans comprehensive reform of drug regulations

02/27/2013 | Regulatory Focus

China's State Food and Drug Administration has announced plans for wide-ranging changes in its drug regulatory process. The plan will foster research and development through a more favorable regulatory environment; update the national strategy for generic drugs; boost the quality of pharmaceutical clinical trials and how they are managed; and encourage the creation of more pediatric pharmaceuticals.

View Full Article in:

Regulatory Focus

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC